Phase III Randomised Study of Bevacizumab plus Chemotherapy versus Chemotherapy alone in Patients with Platinum Resistant Ovariumcancer.
Study sites
- UZ Leuven
- St Elisabeth Namur
- Institut Jules Bordet, Brussels
- UZ Antwerpen
Phase III Randomised Study of Bevacizumab plus Chemotherapy versus Chemotherapy alone in Patients with Platinum Resistant Ovariumcancer.